The design of anti-inflammatory drugs: some considerations based on pessimism, molecular pharmacology and cellular pathology.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000494:pharmacology*; D001681:Biological Assay; D055598:Chemical Phenomena; D002621:Chemistry; D006632:Histamine / Q000502:physiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007249:Inflammation / Q000276:immunology / Q000473:pathology; D051381:Rats; D012701:Serotonin / Q000502:physiology
D000893:Anti-Inflammatory Agents; D012701:Serotonin; D006632:Histamine